A Prospective Study of Femtosecond Laser Intracorneal Lensectomi
Myopia, Astigmatism
About this trial
This is an interventional treatment trial for Myopia focused on measuring Myopia, refractive surgery, all femtosecond laser, ReLEx flex, ReLEx smile
Eligibility Criteria
Inclusion Criteria:
- 25 to 45 years,
- moderate to high myopia with astigmatism =< 2 D,
- otherwise eye healthy,
- CDVA of 0.8 or better (Snellen).
Exclusion Criteria:
- systemic or ocular disease or previous eye surgery,
- thin cornea,
- a difference of more than 2 D myopia in the eyes of each subject.
Sites / Locations
- Department of Ophthalmology Aarhus Sygehus - Aarhus University Hospital, Denmark
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Carl Zeiss Meditech VisuMax laser - ReLEx flex
Carl Zeiss Meditech VisuMax laser - ReLEx smile
>30 patients will receive treatment for myopia with a VisuMax femtosecond laser from Carl Zeiss. The laser can cut with two different settings, called ReLEx flex and ReLEx smile. One eye will recieve ReLEx flex, and the other ReLEx smile
>30 patients will receive treatment for myopia with a VisuMax femtosecond laser from Carl Zeiss. The laser can cut with two different settings, called ReLEx flex and ReLEx smile. One eye will recieve ReLEx flex, and the other ReLEx smile